Related Experiment Videos
Acute eosinophilic pneumonia secondary to daptomycin: a report of three cases
Becky A Miller1, Alice Gray, Thomas W Leblanc
1Division of Infectious Diseases, Duke University Medical Center, Durham, North Carolina, USA. becky.miller@duke.edu
Abstract:
We describe 3 cases of daptomycin-induced pulmonary toxic effects that are consistent with drug-induced acute eosinophilic pneumonia. Patients presented similarly with dyspnea, cough, hypoxia, and diffuse ground-glass opacities at chest computed tomography. Clinical suspicion for this adverse drug event and cessation of daptomycin until definitive diagnosis can be made is crucial.
Insights
Daptomycin can cause acute eosinophilic pneumonia, a serious lung condition. Early recognition and stopping daptomycin are vital for patient recovery.
Area of Science:
- Pulmonology
- Pharmacology
- Toxicology
Background:
- Daptomycin is a lipopeptide antibiotic used for Gram-positive bacterial infections.
- Adverse drug reactions can significantly impact patient outcomes.
- Pulmonary toxicity is a rare but serious complication of certain medications.
Observation:
- Three patients presented with dyspnea, cough, and hypoxia.
- Chest computed tomography revealed diffuse ground-glass opacities in all patients.
- Clinical presentation was consistent with acute eosinophilic pneumonia.
Findings:
- The observed pulmonary toxic effects were directly linked to daptomycin administration.
- Cessation of daptomycin led to clinical improvement in the described cases.
- Diagnosis requires a high index of clinical suspicion for adverse drug events.
Implications:
- Clinicians should consider daptomycin-induced pulmonary toxicity in patients with compatible symptoms.
- Prompt identification and discontinuation of daptomycin are crucial for managing this adverse event.
- Further research into the mechanisms of daptomycin-induced lung injury may inform preventative strategies.
Related Concept Videos
Atypical Pneumonia
Pneumonia III: Complications and Assessment
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Rocky Mountain Spotted Fever
Acute Pyelonephritis II: Diagnostic Studies and Management